Search research articles
Contact Us
Filters
Showing results (161-170 of 201) with videos related to
Page
of 21
Sort By:
Alimentary Pharmacology & Therapeutics
|
August 6, 1998
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer
G Dobrilla, G Di Matteo, M Dodero, et al.
The Review of Scientific Instruments
|
August 1, 1978
Multiwire proportional chamber system of the Fermilab single arm spectrometer
E F Anelli, M T Chiaradia, C De Marzo, et al.
Acta Ophthalmologica Scandinavica. Supplement
|
February 11, 1999
Molecular basis of open-angle glaucoma in Italy
A Angius, M Pisano, A Sanca, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2021
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
Alessio Cortellini, Katia Cannita, Marcello Tiseo, et al.
ESMO Open
|
April 4, 2022
Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406]
L Cantini, G Mentrasti, G Lo Russo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
ESMO Gastrointestinal Oncology
|
May 22, 2026
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study
H Vandeputte, A Casadei-Gardini, F Peeters, et al.
ESMO Open
|
July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis
S Camera, A Vogel, M Rimini, et al.
The Astrophysical Journal
|
January 14, 2022
Investigating the Nature of Late-Time High-Energy GRB Emission Through Joint <i>Fermi /Swift</i> Observations
M Ajello, L Baldini, G Barbiellini, et al.
Physical Review Letters
|
March 18, 2017
Search for Cosmic-Ray Electron and Positron Anisotropies with Seven Years of Fermi Large Area Telescope Data
S Abdollahi, M Ackermann, M Ajello, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 201) with videos related to
Sort By:
Page
of 21
Alimentary Pharmacology & Therapeutics
|
August 6, 1998
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer
G Dobrilla, G Di Matteo, M Dodero, et al.
The Review of Scientific Instruments
|
August 1, 1978
Multiwire proportional chamber system of the Fermilab single arm spectrometer
E F Anelli, M T Chiaradia, C De Marzo, et al.
Acta Ophthalmologica Scandinavica. Supplement
|
February 11, 1999
Molecular basis of open-angle glaucoma in Italy
A Angius, M Pisano, A Sanca, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2021
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
Alessio Cortellini, Katia Cannita, Marcello Tiseo, et al.
ESMO Open
|
April 4, 2022
Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406]
L Cantini, G Mentrasti, G Lo Russo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
ESMO Gastrointestinal Oncology
|
May 22, 2026
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study
H Vandeputte, A Casadei-Gardini, F Peeters, et al.
ESMO Open
|
July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis
S Camera, A Vogel, M Rimini, et al.
The Astrophysical Journal
|
January 14, 2022
Investigating the Nature of Late-Time High-Energy GRB Emission Through Joint <i>Fermi /Swift</i> Observations
M Ajello, L Baldini, G Barbiellini, et al.
Physical Review Letters
|
March 18, 2017
Search for Cosmic-Ray Electron and Positron Anisotropies with Seven Years of Fermi Large Area Telescope Data
S Abdollahi, M Ackermann, M Ajello, et al.
Page
of 21